BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 17140951)

  • 1. Angiogenin-A Proposed Biomarker for Cardiovascular Disease-Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease.
    Höbaus C; Pesau G; Zierfuss B; Koppensteiner R; Schernthaner GH
    Angiology; 2021 Oct; 72(9):855-860. PubMed ID: 33779308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine.
    Damasceno PKF; de Santana TA; Santos GC; Orge ID; Silva DN; Albuquerque JF; Golinelli G; Grisendi G; Pinelli M; Ribeiro Dos Santos R; Dominici M; Soares MBP
    Front Cell Dev Biol; 2020; 8():737. PubMed ID: 32974331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author`s Reply.
    Gurses KM; Yalcin MU; Kocyigit D
    Anatol J Cardiol; 2019; 22(4):210-211. PubMed ID: 31584442
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoxia Rapidly Induces the Expression of Cardiomyogenic Factors in Human Adipose-Derived Adherent Stromal Cells.
    Choi JW; Moon H; Jung SE; Lim S; Lee S; Kim IK; Lee HB; Lee J; Song BW; Kim SW; Hwang KC
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31443313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between serum angiogenin and osteopontin levels and coronary collateral circulation in patients with chronic total occlusion.
    Gürses KM; Yalçın MU; Koçyiğit D; Beşler MS; Canpınar H; Evranos B; Yorgun H; Şahiner ML; Kaya EB; Özer N; Güç D; Aytemir K; Tokgözoğlu L
    Anatol J Cardiol; 2019 Aug; 22(2):77-84. PubMed ID: 31375653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell-derived angiogenin promotes primodial follicle survival and angiogenesis in transplanted human ovarian tissue.
    Zhang Y; Xia X; Yan J; Yan L; Lu C; Zhu X; Wang T; Yin T; Li R; Chang HM; Qiao J
    Reprod Biol Endocrinol; 2017 Mar; 15(1):18. PubMed ID: 28274269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow-derived mesenchymal stem cells for the treatment of heart failure.
    Narita T; Suzuki K
    Heart Fail Rev; 2015 Jan; 20(1):53-68. PubMed ID: 24862087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy.
    Mendel TA; Clabough EB; Kao DS; Demidova-Rice TN; Durham JT; Zotter BC; Seaman SA; Cronk SM; Rakoczy EP; Katz AJ; Herman IM; Peirce SM; Yates PA
    PLoS One; 2013; 8(5):e65691. PubMed ID: 23741506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells.
    Hsiao ST; Lokmic Z; Peshavariya H; Abberton KM; Dusting GJ; Lim SY; Dilley RJ
    Stem Cells Dev; 2013 May; 22(10):1614-23. PubMed ID: 23282141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac cell therapy: boosting mesenchymal stem cells effects.
    Samper E; Diez-Juan A; Montero JA; Sepúlveda P
    Stem Cell Rev Rep; 2013 Jun; 9(3):266-80. PubMed ID: 22350458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing stem cell function for the treatment of ischemic heart disease.
    Herrmann JL; Abarbanell AM; Weil BR; Manukyan MC; Poynter JA; Brewster BJ; Wang Y; Meldrum DR
    J Surg Res; 2011 Mar; 166(1):138-45. PubMed ID: 20828719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.
    Mimeault M; Batra SK
    Stem Cell Rev; 2008; 4(1):27-49. PubMed ID: 18288619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic modification of stem cells for transplantation.
    Phillips MI; Tang YL
    Adv Drug Deliv Rev; 2008 Jan; 60(2):160-72. PubMed ID: 18031863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of angiogenin-overexpressing mesenchymal stem cells synergistically augments cardiac function in a porcine model of chronic ischemia.
    Huang SD; Lu FL; Xu XY; Liu XH; Zhao XX; Zhao BZ; Wang L; Gong DJ; Yuan Y; Xu ZY
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1329-38. PubMed ID: 17140951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction.
    Liu XH; Bai CG; Xu ZY; Huang SD; Yuan Y; Gong DJ; Zhang JR
    Microvasc Res; 2008 May; 76(1):23-30. PubMed ID: 18462761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes.
    Sartore S; Lenzi M; Angelini A; Chiavegato A; Gasparotto L; De Coppi P; Bianco R; Gerosa G
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):677-84. PubMed ID: 16188450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells".
    Atoui R; Shum-Tim D; Chiu RC
    Ann Thorac Surg; 2008 Jul; 86(1):327-34. PubMed ID: 18573459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in angiogenin and therapeutic angiogenesis].
    Tang CH; Guo HL
    Sheng Li Ke Xue Jin Zhan; 2011 Jun; 42(3):210-3. PubMed ID: 21932520
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.